Standout Papers

From bench to bedside – preclinical and early clinical development of the anticancer agent ... 2005 2026 2012 2019 855
  1. From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A) (2006)
    Christian G. Hartinger, Stefanie Zorbas‐Seifried et al. Journal of Inorganic Biochemistry
  2. Antitumour metal compounds: more than theme and variations (2007)
    Michael A. Jakupec, M. Galanski et al. Dalton Transactions
  3. KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients (2008)
    Christian G. Hartinger, Michael A. Jakupec et al. Chemistry & Biodiversity
  4. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches (2005)
    M. Galanski, Michael A. Jakupec et al. Current Medicinal Chemistry
  5. NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application (2014)
    Robert Trondl, Petra Heffeter et al. Chemical Science
  6. Interactions of Antitumor Metallodrugs with Serum Proteins:  Advances in Characterization Using Modern Analytical Methodology (2006)
    Andrei R. Timerbaev, Christian G. Hartinger et al. Chemical Reviews
  7. Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development (2017)
    Samuel M. Meier, Christopher Gerner et al. Chemical Society Reviews

Immediate Impact

3 by Nobel laureates 181 standout
Sub-graph 1 of 13

Citing Papers

Luminescent Lanthanides in Biorelated Applications: From Molecules to Nanoparticles and Diagnostic Probes to Therapeutics
2025 Standout
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
2024 Standout
8 intermediate papers

Works of Bernhard K. Keppler being referenced

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro
2019
Metal Drugs and the Anticancer Immune Response
2018
and 12 more

Author Peers

Author Last Decade Papers Cites
Bernhard K. Keppler 19623 15438 8164 701 31.2k
Peter J. Sadler 25066 21042 12150 688 44.5k
Paul J. Dyson 17138 25053 6603 860 50.7k
Arthur E. Martell 7208 7707 3826 574 25.9k
Trevor W. Hambley 8805 7875 3722 509 16.4k
Angela Casini 7415 11060 8434 293 19.2k
Luigi Messori 8756 6610 4849 384 15.6k
Zijian Guo 8116 6731 8151 503 27.1k
Helmut Sigel 6015 3912 6976 401 16.9k
Rudi van Eldik 5950 7343 3527 882 21.5k
Edward I. Solomon 15052 9027 13659 723 58.4k

All Works

Loading papers...

Rankless by CCL
2026